Barak Ben-Eliezer is the founder and managing partner of DEEP INSIGHT – the only Israeli fund investing in the full spectrum of Deep Tech across all stages.

Based on his experience from TALPIOT Program (as a cadet, a graduate, and the commander of the unit), Barak founded the “Einstein Network” – a global network for the future of mankind, and the President’s Program for Nurturing the State of Israel’s Future Scientists and Inventors (FUTURE SCIENTISTS).

Barak was a special advisor in the fields of Strategy and Technology to the Police Commissioner and to the National Security Council, COO of XIV which was acquired by IBM, and the founder and managing partner of WINNOVATION — a private fund investing in early-stage startups.

He holds a B.Sc. in Mathematics, Physics and Computers, and a M.A. in History, Philosophy and Sociology of Science at the Hebrew University in Jerusalem.

Prof. Uriel Levy is the head of the nano-opto lab and the director of the center for nanoscience and nanotechnology at the Hebrew University, Jerusalem Israel. His research spans over diverse aspects of nanophotonics and light-matter interactions, with focus on device-oriented research. Over the years, he pioneered several key concepts in nanophotonics, including silicon-based photodetection in the short wave infrared (SWIR), nanoscale polarization optics, and the chip-scale atomic vapor technology. Prof. Levy is the co-founder of TriEye, where he is developing CMOS based cost-effective SWIR imaging solutions for the automotive industry and for other verticals. He was also a co-founder and a VP R&D of Civcom, where he developed solutions for optical telecommunications. Over the years, Prof. Levy published over 150 journal papers, presented his results in hundreds of invited talks and he holds dozens of patents. Prof. Levy is a fellow of the optical society of America and is the recipient of several notable honors, including the Kaye innovation award, an ERC consolidator grant, the President Young Investigator Award of the Hebrew University of Jerusalem, and the Rothschild Post-Doctoral Fellowship. He holds a BSc in Physics and materials science from the Technion and a PhD in electro optics from the Tel Aviv University. Prior to joining the Hebrew University, he spent nearly four years as a researcher in the University of California, San Diego.

Oren Bar-On is a former Senior Partner at EY, where he led the firm’s technology practice, which audits more than 50% of the Israeli startups funded by VCs or other investors. Oren was with EY since 1993 and has substantial experience in providing audit and advisory services to U.S. SEC registrants, startup companies, VC’s and PE’s. He now focuses and offers consulting services regarding M&As (buy-side and sell-side), private offerings, IPOs and ongoing tax consulting to companies. Oren is a significant figure in the Israeli tech ecosystem: He serves as a guest speaker at technology accounting courses at Israeli universities, participates in key conferences, frequently grants interviews to Israel’s top economic magazines regarding local and global technology trends, and more. He holds a MA in Diplomacy and Security from Tel Aviv University and a BA in Economics and Accounting from Ben Gurion University.

Ori is the Co-Founder of Biond. He serves as the company’s CFO and a member of its Board of Directors since inception. Prior to launching Biond, Ori was Co-Founder, CFO & Deputy CEO and Director at RedHill Biopharma (NASDAQ: RDHL), a late stage drug development company. During his time at RedHill he led the company’s IPO in the Tel-Aviv Stock Exchange and its dual listing on NASDAQ including several private and public financing rounds totaling over $100 million as well as overseeing two phase 3 and three phase 2 trials. Prior to RedHill, Ori was partner in ProSeed Capital Holding CVA, a Belgium-based boutique investment firm, responsible for investments and banking activities in Israel. Ori has over 20 year of experience in investment banking and consultancy for the pharma/biotech field and as a Co-Founder of pharma/biotech companies.

Background
Dita Bronicki, one of the first businesswomen and female entrepreneurs in Israel, is a pioneer in her field. Together with her husband, Yehuda Bronicki, they founded, managed, and led the Ormat Group and its global business for five decades. Together, Dita and Yehuda turned Ormat into a world leader in geothermal energy. They have implemented a unique leadership style that combines participatory and empowering management principles, setting a personal example, and fulfilling a vision to establish a leading export industry in Israel, focused on innovative technologies, unique business approaches, and continuous contributions to the community.

The ORT Ormat School highlights their outstanding community outreach, with more students than employees, in the founding year of 1970. Over the years, ORT Ormat have become executives, managers, and engineers, in their field of training. After her retirement, Dita expanded her public activities in technological education (serving on various committees and public boards in the field), to promote Israeli industries, as well as dialog between Jews and Arabs in Israel.

While leading Ormat’s day-to-day management and its financial and business management Dita has been a role model for Ormat employees. Dita remains a paramount figure for women around the world since taking on senior management at a time when very few women held such roles.

Awards
Among numerous awards, Dita received the Israel Prize in 2018

Prof. Palmon was born in Israel and trained at the Hebrew University, where he received his DMD diploma in 1988. He then pursued graduate studies in cellular biology completing his Ph.D in 1991. Following a two-year postdoctoral appointment at the Weizmann Institute, he joined the Institute of Dental Sciences at the Hebrew university. Prof. Palmon is currently serving as the vice president for research and development at the Hebrew University.

Prof. Palmon developed technologies promoting the diagnostic value of Oral Fluids (OF) for both local and systemic diseases. OF as a diagnostic fluid has many advantages over serum. OF are easy to collect, store and ship and can be obtained at low cost in sufficient quantities for analysis. For patients, the non-invasive collecting techniques dramatically reduce anxiety and discomfort and simplify procurement of repeated samples for longitudinal monitoring over time.  His work was supported by various research agencies including the Israeli Science Foundation, United States-Israel Binational Science Foundation, German-Israel Science Foundation, Ministry of Sciences and Ministry of Health. Recently he founded a Hebrew University spin off company named Salignostics to translate this new knowledge to home use rapid diagnostic tests.

Yishai M. Fraenkel serves as Vice President and Director General of the Hebrew University of Jerusalem since his appointment in October 2017. In this capacity he is responsible for the University’s administration, finance and infrastructure.

In the years 1998-2017 Mr. Fraenkel worked for the Intel Corporation, a global technology powerhouse and a Fortune-50 company. Between 2014 and 2017 he served as Vice-President in the company’s New Technologies Group. The global organization he led was responsible for the corporate software and algorithm development in the fields of computer vision and artificial intelligence. From 2007 until 2014 he was the General Manager of the Intel Jerusalem site, a design center of some 1200 engineers. His technology responsibilities covered cyber-security and manageability. In addition, between 1998 and 2007 he held various managerial roles in Intel, both in Israel and in the United States.

Mr. Fraenkel served as a board member of Israel’s Planning and Budgeting Committee (PBC). The PBC is the Council for Higher Education’s entity responsible for the planning and budgeting of Israel’s higher education system – over 60 universities and colleges. In this role, he was directly responsible for the STEM activities as well as integration of minorities (particularly the ultra-Orthodox Haredi society as well as the Arab society).

Previously Mr. Fraenkel held board positions in several institutions, touching on entrepreneurship, higher education, K12-education and integrating minorities into the workplace.

Mr. Fraenkel holds a B.Sc. degree in Mathematics and Computer Science (Hebrew University, 1995), a B.A degree in History (Open University of Israel, 2008) and an MBA (Hebrew University, 2001). He currently teaches at the Hebrew University.

He lives in Modiin, he is married to Merav – a physician, and is a proud father of 5 children.